syringe

Major League Baseball releases its annual drug test report

30 Comments

The annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator has been released by Major League Baseball. The stats:

  • There were 5,391 total drug tests. 4,022 were urine samples, 1,369 were blood samples;
  • There were eight positive tests resulting in discipline. All were for stimulants. Seven of the stimulant tests were for Adderall. One for Methylhexaneamine. I guess that means that there are no more steroids in baseball. Yay!
  • There were 13 “non-analytical positives.” That’s baseball code for “Biogenesis dudes.”
  • There were 122 therapeutic use exemptions for otherwise banned drugs.  119 of them were for ADD drugs like Adderall. Three were three for hypogonadism. A couple of years ago here was only one for hypogonadism, so that’s on the uptick. On the bright side, two years ago there was a therapeutic use exemption for narcolepsy and now there is none. So the narcoleptic either got better or retired.

The most interesting thing here, to me anyway, continues to be the number of Adderall-users in baseball. It’s estimated that 4.7% of the adult population has ADD. 119 of roughly 1,200 major leaguers on 40-man rosters puts the ADD rate at nearly 10%. Back that number down a little bit for the various guys that shuffle in and out of 400-man rosters and you figure that baseball players have ADD diagnosis at around twice the level of that in the normal population.

Are baseball players more likely to have ADD than the rest of the adult population? Are they just more likely to be diagnosed that way? Or are therapeutic use exemptions for ADD drugs a means of getting something ballplayers have always found beneficial — stimulants — in a legal way?

Nationals will add Mat Latos to the roster on Thursday

ARLINGTON, TX - MAY 11:  Mat Latos #38 of the Chicago White Sox pitches against the Texas Rangers in the bottom of the first inning at Globe Life Park in Arlington on May 11, 2016 in Arlington, Texas.  (Photo by Tom Pennington/Getty Images)
Tom Pennington/Getty Images
Leave a comment

Thursday is September 1, which means rosters expand. As a result, the Nationals plan to promote pitcher Mat Latos to the major league roster, Ken Rosenthal of FOX Sports reports. Latos had an opt-out clause for Monday, but after discussing the matter with the team, he agreed to stay at Triple-A Syracuse until Thursday.

Latos, 28, put up a 4.62 ERA over 11 starts with the White Sox before being released in mid-June. Nearly two weeks later, he signed a minor league contract with the Nationals.

In the Nationals’ minor league system, Latos has made three starts for the club’s Gulf Coast League team as well as three for Syracuse. In aggregate, the right-hander has yielded six runs (four earned) on 20 hits and 10 walks with 28 strikeouts in 28 innings.

Latos will likely pitch out of a long relief role for the Nationals and can be used as starting rotation insurance as well.

John Gibbons texts Mark Buehrle, “You know, rosters expand in September.”

ST. PETERSBURG, FL - OCTOBER 2:  Mark Buehrle #56 of the Toronto Blue Jays pitches during the second inning of a game against the Tampa Bay Rays on October 2, 2015 at Tropicana Field in St. Petersburg, Florida.  (Photo by Brian Blanco/Getty Images)
Brian Blanco/Getty Images
6 Comments

Mark Buehrle hasn’t officially retired, but he hasn’t thrown a pitch in professional baseball since last October. Still, the Blue Jays wouldn’t mind having some insurance, so manager John Gibbons recently texted Buehrle, “You know, rosters expand in September,” Sportsnet’s Ben Nicholson-Smith reports.

Buehrle’s response? He texted back a picture of a lake. Sounds like he’s not interested in making a return, at least this year.

Last year, at the age of 36, Buehrle went 15-8 with a 3.81 ERA with a 91/33 K/BB ratio in 198 2/3 innings while leading the league with four complete games. He fell 1 1/3 innings shy of a 15th consecutive 200-inning season. There are many worse ways to end a career.